PI
REGN icon

PGGM Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

PGGM Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.7M Hold
92,584
– – 1.42% 29
2026
Q1 		$71.5M Hold
92,584
– – 1.25% 31
2025
Q4 		$71.5M Hold
92,584
– – 1.13% 38
2025
Q3 		$52.1M Buy
92,584
+8,187
+10% +$4.63M 0.84% 46
2025
Q2 		$44.3M Buy
84,397
+51,900
+160% +$29M 0.77% 49
2025
Q1 		$20.6M Hold
32,497
– – 0.28% 72
2024
Q4 		$23.1M Buy
32,497
+6,300
+24% +$5.29M 0.31% 56
2024
Q3 		$27.5M Sell
26,197
-6,531
-20% -$7.27M 0.35% 54
2024
Q2 		$34.4M Sell
32,728
-3,301
-9% -$3.2M 0.49% 46
2024
Q1 		$34.7M Hold
36,029
– – 0.5% 48
2023
Q4 		$31.6M Sell
36,029
-20,613
-36% -$17M 0.48% 51
2023
Q3 		$46.6M Buy
56,642
+2,004
+4% +$1.57M 0.8% 32
2023
Q2 		$39.3M Buy
54,638
+4,436
+9% +$3.42M 0.64% 39
2023
Q1 		$41.2M Buy
50,202
+2,439
+5% +$1.84M 0.69% 38
2022
Q4 		$34.5M Buy
47,763
+3,089
+7% +$2.28M 0.6% 40
2022
Q3 		$30.8M Buy
+44,674
New +$28.1M 0.54% 42
2022
Q1 		$5.55M Hold
8,791
– – 0.03% 292
2021
Q4 		$5.55M Buy
+8,791
New +$5.4M 0.03% 292
2020
Q4 		– Sell
-69,444
Closed -$38.9M – 360
2020
Q3 		$38.9M Buy
69,444
+21,489
+45% +$13M 0.2% 120
2020
Q2 		$29.9M Buy
+47,955
New +$27.2M 0.17% 138

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

PGGM Investments's REGN Position: Q2 2026 in Review

PGGM Investments held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 92,584 shares worth $57.7M. The position accounts for 1.42% of the portfolio, ranked #29.

PGGM Investments first reported a position in REGN in Q2 2020 and has held it in 20 quarters since. The position peaked at $71.5M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • PGGM Investments held 92,584 shares of Regeneron Pharmaceuticals worth $57.7M as of Q2 2026.
  • PGGM Investments left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 1.42% of PGGM Investments's portfolio in Q2 2026, its #29 holding.
  • PGGM Investments first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
  • PGGM Investments's Regeneron Pharmaceuticals position peaked at $71.5M in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on PGGM Investments's 13F filing for Q2 2026, filed 12 Aug 2026.